Merck Canada Inc. (Canada)

Recent papers from Merck Canada Inc. (Canada)

1. Projected epidemiological impact of lowering the adult pneumococcal vaccination age from 60 to 50 years in GermanyHuman Vaccines & Immunotherapeutics · 2026
2. Estimating and Projecting Efficacy of Monoclonal Antibodies Against Respiratory Syncytial Virus Beyond Clinical Trial PeriodsVaccines · 2026
3. Surveillance of zoonotic and production-limiting pathogens in invasive free-ranging wild pigs in Alberta, CanadaBMC Veterinary Research · 2026
4. Obesity and Women’s Health Across the Lifespan: A Clinical Review of Life Stage–Specific Challenges and Treatment ConsiderationsObesity Pillars · 2026
5. Effects of anthelmintics and gastrointestinal nematode infection intensity on growth and production performance and carcass quality in Western Canadian feedlot cattleTranslational Animal Science · 2026
6. Estimating the Long-Term Clinical and Economic Impact of Universal Varicella Vaccination in Portugal Using a Dynamic Transmission ModelPharmacoEconomics - Open · 2026
7. Clinical impact of childhood and adolescence dengue vaccination in Indonesia: A dynamic transmission modeling studyEpidemics · 2026
8. A System-Level Framework for Evaluating Privacy in Hybrid LLM DeploymentsAlgorithms · 2026
9. Considerations for Pre-deployment Planning in Point-of-Care Ultrasound Program Implementation: A HIMSS-SIIM Enterprise Imaging Community Whitepaper in Collaboration with AIUMJournal of Imaging Informatics in Medicine · 2026
10. Assessing the Impact on Health and Productivity Outcomes of Anti-PD-(L)1 Agents to Treat Early-Stage Cancers in ItalyClinical Drug Investigation · 2026
11. Animal welfare and sustainability in pork production: a pilot study of farmer and veterinarian perspectives in North AmericaPorcine Health Management · 2026
12. Fully automatic left ventricle segmentation in ⁸²Rb PET/CT Using a semi-supervised nnU-netEJNMMI Research · 2026
13. Epidemiological impact of a 20- or 21-valent pneumococcal conjugate vaccine in the Japan adult population: insights from a dynamic transmission modelExpert Review of Vaccines · 2026
14. Cost-Effectiveness Analysis of Clesrovimab for Respiratory Syncytial Virus in Infants in the United StatesVaccines · 2026
15. From survey to solutions: Tackling diversity and inclusion gaps through an inclusion task forceEpidemics · 2026
16. Safety Profiles of Polymyxins, Aminoglycosides, and Imipenem/Cilastatin/Relebactam (IMI/REL) in the Treatment of Gram-Negative Infections: A Literature ReviewAntibiotics · 2026
17. Socioeconomic Burden of Pulmonary Arterial Hypertension in Patients and Caregivers: A Canadian Cross-sectional StudyCJC Open · 2026
18. Extrapolation of Time-to-Event Survival Outcomes of Histology-Independent Therapies Using a Bayesian Hierarchical ModelMedical Decision Making · 2026
19. The effect of dose timing schedule on live performance, carcass cutting yields, and fat quality of market gilts managed using GnRF immunizationTranslational Animal Science · 2026
20. Impact of a 21-valent pneumococcal conjugate vaccine on pneumococcal disease incidence among adults 65–84 years of age in Belgium: An epidemiological modeling studyHuman Vaccines & Immunotherapeutics · 2026